Trial Profile
Phase I/II study of temsirolimus for the treatment of unresectable hepatocelluar carcinoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 27 Oct 2015 New trial record